baber/WOPTO huggingface dataset:
Patent EP-4256576-A1 (EP)
Title: A system and method for scanning and controlling storage of an injection device
Inventor: KIETZMANN HARDY
IPC: G16H20/17
Filed: 2021-12-01
Abstract: A system comprising a user device and a storage device configured to communicate wirelessly with each other. The user device can comprise a processor, a memory, and a wireless transceiver. The storage device can comprise a plurality of openings, wherein each opening is configured to store an unused injection device for a period of time and wherein each opening has an associated sensor, and a storage device wireless transceiver. The user device can be configured to scan a first injection device to determine at least one of a drug dosage contained within the first injection device and a device expiration date of the first injection device, and create first device data relating to at least one of the drug dosage and the device expiration date and associate the first device data with a first opening of the plurality of openings of the storage device. And the storage device can be configured to detect whether the first injection device has been placed in, or removed from, the first opening.
Patent EP-4161813-A1 (EP)
Title: Braking device for working machine
Inventor: LOPONEN JANNE
IPC: B60W10/18
Filed: 2021-06-01
Abstract: A pressure medium operated braking device (1) for a working machine. The working brake (1) comprises a working brake (10), parking brake (20), and, shared by the working brake (10) and parking brake (20), a brake disc stack (4) which comprises alternately at least one friction disc (5) and at least one mating disc (6) forming a counterpiece for said at least one friction disc (5). The braking device (6) comprises at least one sensor arrangement (30) for indicating the condition of the brake disc stack (4) of the braking device (1). In addition, an arrangement and method for producing information indicative of the operating ability of the brake in a working machine.
Patent EP-4166657-A1 (EP)
Title: Recombinant herpes simplex virus comprising glycoprotein gh that has been modified for retargeting, and use thereof
Inventor: KWON HEECHUNG
IPC: C07K16/32
Filed: 2021-02-19
Abstract: Proposed are a recombinant herpes simplex virus having a modified glycoprotein gH for retargeting and the use thereof. Particularly, the recombinant herpes simplex virus is capable of infecting a target cell having a target molecule to which a cell-targeting domain specifically recognizes and binds due to the presence of the cell-targeting domain in the glycoprotein gH thereof, and is thus useful for anticancer therapy or gene therapy.
Patent EP-4255662-A1 (EP)
Inventor: MAGERL CHRISTIAN
IPC: B23K9/095
Filed: 2021-11-30
Abstract: Um einen stabilen Schweißprozess zu ermöglichen wird ein Schweißgerät (2) durch eine Energiequelle (2) mit einer Versorgungsleistung (P 1 ) versorgt und wandelt zur Erzeugung eines Schweißlichtbogens (arc) zumindest einen Teil der Versorgungsleistung (P 1 ) in eine Schweißleistung (P 2 ), wobei die Schweißleistung (P 2 ) durch Vorgabe eines Schweißstroms (I 2 ) geregelt wird. Dazu wird die Versorgungsspannung (U 1 ) ermittelt und ein maximaler, von der Energiequelle (2) an das Schweißgerät (1) abgebbarer Versorgungsstrom (I 1,max ) vorgegeben. Unter Verwendung der Versorgungsspannung (U 1 ) und dem maximalen Versorgungsstrom (I 1,max ) wird eine maximale Versorgungsleistung (P 1,max ) berechnet. Aus der maximalen Versorgungsleistung (P 1,max ) wird eine maximale vom Schweißgerät (1) abgegebene Schweißleistung (P 2,max ) ermittelt und die Schweißleistung (P 2 ) auf die maximale abgebbare Schweißleistung (P 2,max ) limitiert wird.
Patent EP-4251111-A1 (EP)
Inventor: VIOLA DAVIDE
IPC: A61F13/15
Filed: 2021-11-17
Abstract: A method for applying absorbing inserts in a process for the production of pull-up diapers, comprises: feeding a composite elastic web (11), comprising at least one elastic element, along a path and according to an advancing direction (D), conferring said composite elastic web (11) with an application tension (T2) such that the composite elastic web (11) has an elongation lower than a nominal maximum elongation thereof and the elastic element has a second percentage elastic elongation (Δ2%) lower than first percentage elastic elongation (Δ1%) corresponding to the nominal maximum elongation; applying absorbing inserts (15) on an intermediate portion of the composite elastic web (11) while the composite elastic web (11) advances with said application tension (T2), such that, once the tension is completely released, the absorbing inserts (15) remain substantially flat and do not form substantial folds or wrinkles.
Patent EP-4247321-A1 (EP)
Inventor: RENOCK SEAN MICHAEL
IPC: A61K8/27
Filed: 2021-11-18
Abstract: L'invention concerne une composition de soins personnels qui présente d'excellentes qualités de nettoyage sans l'utilisation, ou l'inclusion, d'un tensioactif sulfaté tout en offrant un avantage antipelliculaire. La composition de soins personnels contient de 7 % à 12 % de cocoyl alaninate de sodium ; 3 % à environ 10 % d'ester glycérolé ; un agent antipelliculaire ; un support liquide ; et la composition de soins personnels étant sensiblement exempte de tensioactifs sulfatés. Le rapport cocoyl alaninate de sodium à l'ester glycérolé peut être de 2 : 1. La viscosité de la composition de soins personnels peut être de 3 mPa-s à 12 Pa-s
Patent EP-4259158-A1 (EP)
Title: Use of cladribine for treating immune brain disease
Inventor: REJDAK KONRAD
IPC: A61K31/7076
Filed: 2021-12-06
Abstract: 2-Chloro-2'-deoxyadenosine, hereinafter referred to as cladribine, or a pharmaceutically acceptable salt thereof may be used in the treatment or amelioration of autoimmune encephalitis, hereinafter referred to as AE, in a patient diagnosed with AE.
Patent EP-4179770-A1 (EP)
Inventor: WU LIANGMING
IPC: H04L1/18
Filed: 2021-05-26
Abstract: Certain aspects of the present disclosure provide techniques for cross layer improvement with radio link control feedback on physical layer. In aspects, a method performed by a user equipment (UE) includes receiving a radio link control (RLC) packet; and transmitting, in response to the RLC packet, an RLC acknowledgment (ACK) or an RLC negative acknowledgment (NACK) on a pre-configured uplink resource associated with the RLC packet.
Patent EP-4175530-A1 (EP)
Title: Self-actuating grasping device
Inventor: CHANG KENNETH CHIH-PING
IPC: A61F2/966
Filed: 2021-07-06
Abstract: An auto-locking grasping device and corresponding method of using the grasping device for retrieving a foreign object from a location in a patient's body. The grasping device has a handle with a self-actuating mechanism, an actuator on the handle coupled to an actuator wire, an elongated shaft member extending distally from the handle with the actuation wire coaxially disposed therein and opposing jaws at a distal end of the elongated shaft member that are coupled to the actuation wire and pivot between open and closed configurations. The self-actuating mechanism has a bias that imparts a closing force to the opposing jaws through the actuation wire. Actuation of the actuator is configured to impart an opening force to the opposing jaws through the actuation wire.
Patent EP-4180496-A1 (EP)
Inventor: WATANABE YOSHINORI
IPC: C09J183/04
Filed: 2021-07-08
Abstract: A provided adhesive is a silicone-based adhesive having an initial adhesive force of 0.2 to 3 N/20 mm and having an adhesive force of 4 N/20 mm or less after heating at 260°C for 30 minutes. A provided adhesive tape includes a cured layer of the above silicone-based adhesive. The adhesive tape may further include a substrate, and the cured layer may be provided on a surface of the substrate. The adhesive tape shows high adhesion performance and is capable of achieving low thermal dependence. The adhesive is capable of forming the adhesive tape.
Patent EP-4256302-A1 (EP)
Inventor: WILL CORNELIA
IPC: G01N5/04
Filed: 2021-11-30
Abstract: Described is a thermogravimetric analyzer system. The system includes an evaporator having first and second fluidic channels and a thermally controlled heater assembly. The first fluidic channel has a first channel inlet in fluidic communication with a gas supply module, a first channel outlet and an end portion extending from the first channel outlet. The second fluidic channel has a second channel inlet in fluidic communication with a source of liquid and a second channel outlet disposed on the first fluidic channel at a merge location between the first channel inlet and the first channel outlet. The end portion of the first fluidic channel includes a bend to redirect a flow within the first fluidic channel and improve a mixing of the gas and liquid received by the first and second fluidic channels, respectively.
Patent EP-4264126-A1 (EP)
Inventor: LELARGE OLIVIER
IPC: F21S43/237
Filed: 2021-12-17
Abstract: The invention relates to an assembly (102) for a light device, comprising: a plurality of optical parts (104) made of moulded plastic material; and at least one flexible link (106) made of plastic material connecting the plurality of optical parts (104). The invention also relates to a method for producing a plurality of optical parts, forming an assembly (102) as above.
Patent EP-4247145-A1 (EP)
Inventor: RIETZ STEFFEN
IPC: A01H1/00
Filed: 2021-12-20
Abstract: The present invention provides methods for identifying or selecting a Brassica plant cell, Brassica plant or part thereof, or a Brassica seed comprising a QTL that confers resistance against clubroot disease. The present invention further provides a nucleic acid comprising a QTL that confers resistance against clubroot disease as well as markers associated therewith, proteins encoded by the nucleic acid, plants or parts thereof, plant cells or seeds comprising the QTL and uses thereof.
Patent EP-4267442-A1 (EP)
Title: Procédé et système de vérification du fonctionnement de moyens de freinage d'au moins un véhicule, et système de mesure de la force de frottement
Inventor: TIONE ROBERTO
IPC: B60T17/22
Filed: 2021-12-22
Abstract: L'invention concerne un procédé de vérification du fonctionnement de moyens de freinage d'au moins un véhicule, plus particulièrement d'un véhicule ferroviaire, comprenant les étapes consistant à : a) imposer une force de freinage (FA) sur au moins une roue (100, 200) dudit au moins un essieu dudit au moins un véhicule (301, 302,..., 303) ; b) remorquer le ou les véhicules selon une vitesse avant non nulle et constante ; c) mesurer sur un rail au moins une force de frottement (FB) qui est une fonction d'une force de freinage (FA) ; d) comparer la ou les forces de frottement mesurées (FB) avec une valeur de force minimale prédéterminée (FBmin) ; e) déterminer que le moyen de freinage associé à la ou aux roues dont la force de frottement (FB) est inférieure à la valeur de force minimale prédéterminée (FBmin) est défectueux. L'invention concerne également un système de mesure d'une force de frottement et un système de vérification du fonctionnement de moyens de freinage d'au moins un véhicule.
Patent EP-4190289-A1 (EP)
Title: Individually-packaged absorbent article and method for manufacturing individually-packaged absorbent article
Inventor: YOSHIBA Megumi
IPC: A61F13/15
Filed: 2021-06-22
Abstract: An individually wrapped absorbent article that includes an absorbent article, and a wrapping sheet configured to wrap the absorbent article is provided. The wrapping sheet is folded toward an inner surface of the wrapping sheet so as to cause a first region including one end in a first direction of the wrapping sheet and a second region including an opposite end in the first direction to overlap with each other, and a seal portion is formed at each edge portion in a second direction of the wrapping sheet. The second direction is perpendicular to the first direction. The seal portion includes a plurality of compressed recesses and compressed projections along the first direction. The compressed projections are formed between the compressed recesses.
Patent EP-4186926-A1 (EP)
Title: Ccr8 antibody and application thereof
Inventor: LU SHUANG
IPC: A61K47/68
Filed: 2021-08-27
Abstract: Involved is an isolated antigen binding protein, being capable of binding CCR8 derived from a primate animal. Further involved are a pharmaceutical composition comprising the antigen binding protein, and an application of the antigen binding protein and/or the pharmaceutical composition in the prevention and/or treatment of a tumor or a cancer.
Patent EP-4203774-A1 (EP)
Inventor: Slomka Piotr
IPC: A61B5/00
Filed: 2021-08-27
Abstract: A deep learning model for the detection of obstructive coronary artery disease (CAD) can take a set of polar maps and patient information as input, then output obstructive CAD scoring data, such as probabilities of obstructive CAD associated with various cardiac territories, as well as an attention map and a CAD scoring map. The model can operate agnostic of camera type used to capture the set of polar maps. The attention map indicates regions of the polar maps important to the deep learning process for that particular set of polar maps. The attention map and obstructive CAD scoring data can be used to generate a CAD scoring map showing CAD probability by segment on a standard 17-segment model of a left ventricle. The attention map and/or CAD scoring map can act as easily explainable tools for interpreting the results of a myocardial perfusion imaging study.
Patent EP-4211218-A1 (EP)
Inventor: LACHHWANI VIKAS
IPC: C11D17/00
Filed: 2021-08-31
Abstract: According the present invention there is provided a soap or detergent bar including: (a) a top surface (1), and; (c) a bottom surface (2), and; (d) a groove (3) running across its top surface from a first end (31) to a second 10 end (32), wherein the height (311) of the first end (31) as measured from the bottom surface (2) is greater than the height (321) of the second end (32) as measured from the bottom surface (2).
Patent EP-4238433-A1 (EP)
Title: Aerosol generation apparatus
Inventor: CHEN HANLIANG
IPC: A24F40/46
Filed: 2021-10-26
Abstract: An aerosol generation apparatus, comprising: a liquid storage unit (12), which is used for storing a liquid capable of generating an aerosol; a heating element (14), which is used for heating the liquid; a liquid transfer unit (13), which is used for transferring the liquid stored in the liquid storage unit (12) to the heating element (14); a power supply (16), which is used for providing power to the heating element (14); and a circuit (15), which is configured to determine, after a specific preset time point of a heating start-up period of the heating element (14), whether the liquid stored in the liquid storage unit (12) is reduced to a threshold value, wherein the preset time point is determined according to the time when the resistance change rate of the heating element (14) is reduced to a first resistance change rate during a heating process, for example, the first resistance change rate is 1% to 30% of the resistance change rate of the heating element (14) during initial heating start-up. After the resistance change rate of the heating element (14) is reduced to a first resistance change rate, whether dry burning occurs in the second half of each instance of vaping can be accurately determined, thus preventing the generation of undesirable harmful gases and a scorched odor, preventing damage to a user's health, and improving the vaping experience of the user.
Patent EP-4251237-A1 (EP)
Title: A driving mechanism of a drug infusion device
Inventor: YANG CUIJUN
IPC: A61M5/145
Filed: 2021-06-08
Abstract: A driving mechanism of a drug infusion device, which comprises: at least one driving unit and at least one driving wheel, the driving unit, moving in the driving direction, can drive the driving wheel to rotate; a linear actuator, electrically connected with the driving unit, pulling the driving unit to move in the driving direction after being powered; a switch unit group, at least comprising a first switch unit and a second switch unit, the first switch unit electrically connected with the linear actuator; a power supply, the power supply, the switch unit group and the linear actuator are electrically connected to form a power supply circuit that supplies power to the linear actuator; when the linear actuator is powered, the driving unit implements driving, and the driving unit can trigger a first signal, indicating the end point of the driving direction, the first switch unit receiving the first signal to turn off to cut off the power to the linear actuator; and a program unit, including a timer electrically connected to the second switch unit, the timer controlling the second switch unit to turn off to cut off the power supply circuit, reducing the power consumption of the infusion device.
Patent EP-4253867-A1 (EP)
Title: Fluid heating system
Inventor: MATSUMOTO AKIHITO
IPC: F24H15/00
Filed: 2021-11-18
Abstract: A heating system (203) includes a heat pump unit (220) that carries out an operation with electric power, a flow circuit (203a), a boiler unit (210) that includes a burner (211) and heats water, and a heating control unit. The heat pump unit (220) includes a heat pump circuit (221) through which a refrigerant circulates. The water heated with the refrigerant flows through the flow circuit (203a). The heating control unit includes an upper limit value acquisition unit and an operation control unit. The upper limit value acquisition unit acquires an upper limit value of the power consumption by the heat pump unit (220). The operation control unit controls the operation of the heat pump unit (220) to maintain the power consumption at a value below the upper limit value in a first time zone during which the power consumption is restricted to a value below the upper limit value. The operation control unit also causes the boiler unit (210) to carry out the operation when an amount of heat applied to the water by the heat pump unit (220) is insufficient in the first time zone.
Patent EP-4257119-A1 (EP)
Inventor: LIM HYE JUNG
IPC: A61K9/16
Filed: 2021-12-01
Abstract: The present invention relates to an olaparib solid dispersion composition having improved stability and bioavailability, and more specifically, to: an olaparib solid dispersion; and an oral composition comprising same, wherein the olaparib solid dispersion includes olaparib, which is a poorly soluble drug, a polymethacrylate copolymer, and a cellulose-based polymer as essential components, has excellent storage stability and thermal stability, and exhibits uniform drug releasability under all of the various pH conditions inside the body.
Patent EP-4263812-A1 (EP)
Inventor: CHEN HONGLIN
IPC: C12N7/04
Filed: 2021-12-10
Abstract: Live attenuated viruses for protection against the novel coronavirus Sars-CoV-2 are provided. The live attenuated chimeric virus strains are based on a live attenuated influenza A or B virus (LAIVA/B), used a master backbone, which includes deletion of the viral virulence element, the NS1 (non-structural protein 1) (DeLNS1), engineered to express one or more antigens of the Sars-CoV-2 (herein, CoV2Ag). The chimeric virus strain is referred to generally herein, as DelNS1-A/B-Sars-CoV-2-CoV2Ag. The DelNS1-A/B-Sars-CoV-2-CoV2Ag strain preferably shows spontaneous cold adaption with preference to grow at 30-33℃. Compositions including the chimeric virus also provided as a co-composition with a LAIVA/B. The DelNS1-A/B-Sars-CoV-2-CoV2Ag strain can be used to protect a subject in need thereof, against a challenge of Sars-CoV-2. The co-compositions can be used to protect a subject in need thereof, against a challenge of Sars-CoV-2 and influenza A and/or B.
Patent EP-4260341-A1 (EP)
Inventor: DOUVILLE CHRISTOPHER
IPC: G16H50/70
Filed: 2021-10-01
Abstract: A method for classifying data using non-negative matrix factorization can include receiving a population of sample data, generating a first matrix of the amplicon counts per sample data, dividing the first matrix into a product of a second matrix and a third matrix, in the second matrix, determining whether each signature is a long or short fragment per each amplicon count, in the third matrix, determining intensities of each signature per the sample data, and classifying the sample data based on the intensities of each signature. The population can include amplicon counts per sample data. The second matrix can include signatures of short and long DNA fragments and the third matrix can include intensities of each signature of the short and long DNA fragments.
Patent EP-4199452-A1 (EP)
Inventor: LIU YAN
IPC: H04L41/083
Filed: 2021-11-24
Abstract: A network data group processing method executed by a terminal, relating to the field of computer networks. The method comprises: generating an initial user interface at a terminal, the initial user interface being used for accessing at least one network data group; in response to a selection operation on the at least one network data group, using a network data group selected from the at least one network data group as a target network data group; in response to an access operation on the target network data group, determining a first target virtual private network (VPN) node corresponding to the target network data group, and establishing a first accelerated access channel between the terminal and the target network data group by means of the first target virtual private network (VPN) node; switching the initial user interface to a first accelerated user interface, wherein the first accelerated user interface displays first network data processing information which is used for indicating that the target network data group is being accessed using the first accelerated access channel.
Patent EP-4272049-A1 (EP)
Title: Method and apparatus for providing non-compute unit power control in integrated circuits
Inventor: PAUL INDRANI
IPC: G06F1/3203
Filed: 2021-12-16
Abstract: Methods and apparatus employ a plurality of heterogeneous compute units and a plurality of non-compute units operatively coupled to the plurality of compute units. Power management logic (PML) determines a memory bandwidth level associated with a respective workload running on each of a plurality of heterogeneous compute units on the IC, and adjusts a power level of at least one non-compute unit of a memory system on the IC from a first power level to a second power level, based on the determined memory bandwidth levels. Memory access latency is also taken into account in some examples to adjust a power level of non-compute units.
Patent EP-4249480-A1 (EP)
Title: Diphenylpyrazole compound, and preparation method therefor and application thereof
Inventor: LIU JIYUAN
IPC: C07D401/12
Filed: 2021-07-12
Abstract: Provided is a diphenylpyrazole-based compound of following formula (I), or its pesticidally acceptable salts, which is a novel inhibitor targeting pest GSTs, has broad inhibitory activities against GSTs in various pests, and can effectively delay the metabolism of insecticides by GSTs in pests, thereby reducing the metabolic resistance of pests to insecticides, and is suitable for use as a synergist for insecticides.
Patent EP-4280005-A1 (EP)
Title: Information presentation system, terminal device, and program
Inventor: KOBAYASHI YOSHIAKI
IPC: G05B23/02
Filed: 2021-03-11
Abstract: In association with a location site of a device within a view field of a user, information regarding the device is presented. In a system including a controller configured to control a device (90) included in a production line, a terminal (30) including a display (32) and a camera (34), and a server (200), the camera has an image capture range including a view field of the display, the controller transmits a light emission command (9A) to the device, the light emission command causing a light emitting unit included in the device to emit light in a predetermined pattern, and the terminal displays information regarding the device in association with a display position in a display area of the display, the display position corresponding to a position of a partial image representing the light emission pattern in a captured image of the camera.